Page last updated: 2024-08-07 15:46:16
Neutrophil elastase
A neutrophil elastase that is encoded in the genome of human. [PRO:CNA, UniProtKB:P08246]
Synonyms
EC 3.4.21.37;
Bone marrow serine protease;
Elastase-2;
Human leukocyte elastase;
HLE;
Medullasin;
PMN elastase
Research
Bioassay Publications (57)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 1 (1.75) | 18.7374 |
1990's | 19 (33.33) | 18.2507 |
2000's | 11 (19.30) | 29.6817 |
2010's | 19 (33.33) | 24.3611 |
2020's | 7 (12.28) | 2.80 |
Compounds (83)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
3,4-dichloroisocoumarin | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
pimagedine | Homo sapiens (human) | IC50 | 72.0000 | 1 | 1 |
stallimycin | Homo sapiens (human) | IC50 | 100.1000 | 2 | 2 |
emodin | Homo sapiens (human) | IC50 | 52.0000 | 1 | 1 |
phenylmethylsulfonyl fluoride | Homo sapiens (human) | IC50 | 73.6905 | 2 | 2 |
2-methylanthraquinone | Homo sapiens (human) | IC50 | 39.0000 | 1 | 1 |
chrysophanic acid | Homo sapiens (human) | IC50 | 18.0000 | 1 | 1 |
physcione | Homo sapiens (human) | IC50 | 6.2000 | 1 | 1 |
bentranil | Homo sapiens (human) | IC50 | 17.0000 | 1 | 1 |
bentranil | Homo sapiens (human) | Ki | 9.5499 | 2 | 2 |
ng-nitroarginine methyl ester | Homo sapiens (human) | IC50 | 2.7000 | 1 | 1 |
closantel | Homo sapiens (human) | IC50 | 25.0000 | 1 | 0 |
lovastatin | Homo sapiens (human) | IC50 | 0.0270 | 1 | 1 |
ursolic acid | Homo sapiens (human) | IC50 | 0.4160 | 1 | 1 |
epigallocatechin gallate | Homo sapiens (human) | IC50 | 12.8000 | 1 | 1 |
midesteine | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
n-benzyloxycarbonylphenylalanyl-valine | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
sivelestat | Homo sapiens (human) | IC50 | 0.1273 | 9 | 9 |
sivelestat | Homo sapiens (human) | Ki | 0.1152 | 4 | 4 |
l 658758 | Homo sapiens (human) | Ki | 1.7000 | 1 | 1 |
e 64 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
4-methyoxybenzoyl-n-glycine | Homo sapiens (human) | IC50 | 25.0000 | 1 | 0 |
l 659286 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
foy 251 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
omega-n-methylarginine | Homo sapiens (human) | IC50 | 0.3000 | 2 | 2 |
l 738167 | Homo sapiens (human) | IC50 | 0.0030 | 2 | 2 |
1-hydroxy-2-methylanthraquinone | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
2-phenyl-1,2-benzisothiazol-3-(2h)-one | Homo sapiens (human) | IC50 | 1.1107 | 1 | 0 |
sb 203580 | Homo sapiens (human) | IC50 | 0.0250 | 1 | 1 |
l 694,458 | Homo sapiens (human) | IC50 | 0.0295 | 2 | 2 |
ono 6818 | Homo sapiens (human) | Ki | 0.0121 | 4 | 4 |
2-(3-nitrophenyl)-3,1-benzoxazin-4-one | Homo sapiens (human) | Ki | 4.3652 | 1 | 1 |
bortezomib | Homo sapiens (human) | Ki | 2.3000 | 1 | 1 |
propolin c | Homo sapiens (human) | IC50 | 22.8000 | 1 | 1 |
propolin c | Homo sapiens (human) | Ki | 15.7000 | 1 | 1 |
N-(3-dibenzofuranyl)-4-morpholinecarboxamide | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
(4-Methyl-2-oxochromen-7-yl) furan-2-carboxylate | Homo sapiens (human) | IC50 | 0.0497 | 1 | 0 |
2-furancarboxylic acid (2-acetyl-1-benzothiophen-3-yl) ester | Homo sapiens (human) | IC50 | 1.5028 | 1 | 0 |
(4-Methoxyphenyl)-(2-methylsulfanyl-6,7-dihydro-[1,4]dioxino[2,3-f]benzimidazol-3-yl)methanone | Homo sapiens (human) | IC50 | 3.5062 | 1 | 0 |
6-fluoro-2-phenyl-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 2.3100 | 1 | 0 |
6-fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 4.8000 | 1 | 0 |
n(6)-(1-iminoethyl)lysine | Homo sapiens (human) | IC50 | 2.4000 | 1 | 1 |
3-chloro-1-(4-methoxyphenyl)-4-(3-methyl-1-piperidinyl)pyrrole-2,5-dione | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
telaprevir | Homo sapiens (human) | IC50 | 5.5600 | 3 | 3 |
2-bromo-6-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-11-pyrido[2,1-b]quinazolinone | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide | Homo sapiens (human) | IC50 | 7.6300 | 1 | 0 |
quercetin | Homo sapiens (human) | IC50 | 18.3390 | 2 | 1 |
quercetin | Homo sapiens (human) | Ki | 11.9000 | 1 | 1 |
apigenin | Homo sapiens (human) | IC50 | 46.1000 | 1 | 1 |
apigenin | Homo sapiens (human) | Ki | 49.9000 | 1 | 1 |
luteolin | Homo sapiens (human) | IC50 | 12.7000 | 1 | 1 |
luteolin | Homo sapiens (human) | Ki | 10.1000 | 1 | 1 |
clavulanic acid | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
amentoflavone | Homo sapiens (human) | IC50 | 1.2700 | 1 | 1 |
robustaflavone | Homo sapiens (human) | IC50 | 1.3300 | 1 | 1 |
camostat mesylate | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
benzyloxycarbonyl-phe-ala-fluormethylketone | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
sb 258719 | Homo sapiens (human) | Ki | 0.0316 | 1 | 2 |
sb 271046 | Homo sapiens (human) | Ki | 3.9811 | 1 | 1 |
N-(4-ethylphenyl)-3-(1-pyrrolyl)propanamide | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
5-Chloro-3-pyridinyl 2-furoate | Homo sapiens (human) | IC50 | 0.7412 | 1 | 0 |
rwj 68354 | Homo sapiens (human) | IC50 | 0.0063 | 1 | 1 |
sb 223245 | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
zd 8321 | Homo sapiens (human) | Ki | 0.0130 | 2 | 2 |
n-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide | Homo sapiens (human) | IC50 | 42.3333 | 3 | 3 |
mdl 101146 | Homo sapiens (human) | Ki | 0.0238 | 3 | 4 |
2-(4-methoxyphenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 5.3500 | 1 | 0 |
2-(4-chlorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 1.1000 | 1 | 0 |
PF-00835231 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
2-(3-chlorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 1.9010 | 1 | 0 |
archazolid a | Homo sapiens (human) | IC50 | 0.3520 | 1 | 1 |
archazolid b | Homo sapiens (human) | IC50 | 0.3160 | 1 | 1 |
5-fluoro-2-phenyl-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 1.0300 | 1 | 0 |
2-(2-fluorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | IC50 | 2.2600 | 1 | 0 |
lyngbyastatin 7 | Homo sapiens (human) | IC50 | 0.0260 | 2 | 2 |
mk-7009 | Homo sapiens (human) | IC50 | 55.0000 | 2 | 2 |
delanzomib | Homo sapiens (human) | IC50 | 3.5500 | 1 | 1 |
bi 201335 | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
6-(3,5-difluoroanilino)-9-(2,2-difluoroethyl)-2-purinecarbonitrile | Homo sapiens (human) | IC50 | 85.1138 | 1 | 1 |
e-6-o-p-coumaroyl scandoside methyl ester | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
2-(3-oxo-1,2-benzothiazol-2-yl)-N-phenylacetamide | Homo sapiens (human) | IC50 | 6.6900 | 1 | 0 |
n-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide | Homo sapiens (human) | IC50 | 0.0120 | 1 | 1 |
n-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide | Homo sapiens (human) | Ki | 0.0120 | 1 | 2 |
4-hydroxy-6-methyl-2-pyrone | Homo sapiens (human) | Ki | 8,128.3100 | 1 | 1 |
elasnin | Homo sapiens (human) | Ki | 93.3254 | 1 | 1 |
rpx7009 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
sulfated pentagalloylglucoside | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
N-[4-(6-chloro-5-nitro-1H-benzimidazol-2-yl)phenyl]acetamide | Homo sapiens (human) | IC50 | 50.0000 | 1 | 0 |
Drugs with Other Measurements
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.Journal of medicinal chemistry, , Jul-13, Volume: 43, Issue:14, 2000
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.Bioorganic & medicinal chemistry letters, , Nov-03, Volume: 8, Issue:21, 1998
Synthesis and in vitro and in vivo evaluation of the 2-(6'methoxy-3',4'-dihydro-1'-naphtyl)-4H-3,1-benzoxazin-4- one as a new potent substrate inhibitor of human leukocyte elastase.Bioorganic & medicinal chemistry letters, , May-03, Volume: 9, Issue:9, 1999
Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase.Journal of medicinal chemistry, , Volume: 33, Issue:2, 1990
Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and In Vivo Biological Evaluation for Acute Lung Injury.Journal of medicinal chemistry, , 02-24, Volume: 65, Issue:4, 2022
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors.Bioorganic & medicinal chemistry, , 01-01, Volume: 29, 2021
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors.Bioorganic & medicinal chemistry letters, , 11-15, Volume: 52, 2021
Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?Journal of medicinal chemistry, , 11-25, Volume: 63, Issue:22, 2020
A BODIPY-Tagged Phosphono Peptide as Activity-Based Probe for Human Leukocyte Elastase.ACS medicinal chemistry letters, , Apr-12, Volume: 9, Issue:4, 2018
Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3.Bioorganic & medicinal chemistry, , Mar-01, Volume: 23, Issue:5, 2015
Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors.Journal of medicinal chemistry, , Dec-12, Volume: 56, Issue:23, 2013
Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.Journal of medicinal chemistry, , Feb-14, Volume: 56, Issue:3, 2013
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.Bioorganic & medicinal chemistry, , Aug-01, Volume: 19, Issue:15, 2011
Clarification of mechanism of human sputum elastase inhibition by a new inhibitor, ONO-5046, using electrospray ionization mass spectrometry.Bioorganic & medicinal chemistry letters, , Sep-02, Volume: 12, Issue:17, 2002
Protease inhibitors: current status and future prospects.Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
3,4-Dihydro-1-isoquinolinamines: a novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency.Bioorganic & medicinal chemistry letters, , Apr-23, Volume: 11, Issue:8, 2001
Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity.Bioorganic & medicinal chemistry letters, , Apr-23, Volume: 11, Issue:8, 2001
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 25, Issue:20, 2015
Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.Bioorganic & medicinal chemistry, , Feb-15, Volume: 16, Issue:4, 2008
Development of orally active nonpeptidic inhibitors of human neutrophil elastase.Journal of medicinal chemistry, , Apr-12, Volume: 44, Issue:8, 2001
Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase.Journal of medicinal chemistry, , Dec-28, Volume: 43, Issue:26, 2000
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.Antimicrobial agents and chemotherapy, , Volume: 54, Issue:1, 2010
Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.Antimicrobial agents and chemotherapy, , Volume: 54, Issue:11, 2010
Protease inhibitors: current status and future prospects.Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase.Journal of medicinal chemistry, , Sep-26, Volume: 40, Issue:20, 1997
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.Antimicrobial agents and chemotherapy, , Volume: 54, Issue:1, 2010
Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.Antimicrobial agents and chemotherapy, , Volume: 54, Issue:11, 2010
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.Journal of medicinal chemistry, , Jul-02, Volume: 41, Issue:14, 1998
Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug.Journal of medicinal chemistry, , Jan-20, Volume: 38, Issue:2, 1995
Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones.Journal of medicinal chemistry, , Dec-23, Volume: 37, Issue:26, 1994
Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.ACS medicinal chemistry letters, , Apr-09, Volume: 11, Issue:4, 2020
Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.Journal of medicinal chemistry, , Feb-14, Volume: 56, Issue:3, 2013
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.Antimicrobial agents and chemotherapy, , Volume: 54, Issue:1, 2010
[no title available]Bioorganic & medicinal chemistry, , 11-15, Volume: 26, Issue:21, 2018
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 25, Issue:20, 2015
Enables
This protein enables 8 target(s):
Target | Category | Definition |
protease binding | molecular function | Binding to a protease or a peptidase. [GOC:hjd] |
transcription corepressor activity | molecular function | A transcription coregulator activity that represses or decreases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription corepressors modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. [GOC:txnOH-2018, PMID:10213677, PMID:16858867] |
endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. [http://merops.sanger.ac.uk/about/glossary.htm#ENDOPEPTIDASE] |
serine-type endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
heparin binding | molecular function | Binding to heparin, a member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. [GOC:jl, ISBN:0198506732] |
peptidase activity | molecular function | Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid. [GOC:jl, ISBN:0815332181] |
cytokine binding | molecular function | Binding to a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity. [GOC:ai, GOC:bf, ISBN:0198599471] |
Located In
This protein is located in 11 target(s):
Target | Category | Definition |
extracellular region | cellular component | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators] |
extracellular space | cellular component | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. [ISBN:0198547684] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
cell surface | cellular component | The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm] |
secretory granule | cellular component | A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules. [GOC:mah, ISBN:0198506732] |
azurophil granule lumen | cellular component | The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid. [GOC:bf, PMID:17152095] |
specific granule lumen | cellular component | The volume enclosed by the membrane of a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase. [GOC:bf, PMID:7334549] |
phagocytic vesicle | cellular component | A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis. [GOC:go_curators, ISBN:0198506732] |
collagen-containing extracellular matrix | cellular component | An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells. [GOC:BHF, GOC:rph, PMID:21123617] |
extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
extracellular space | cellular component | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. [ISBN:0198547684] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
transcription repressor complex | cellular component | A protein complex that possesses activity that prevents or downregulates transcription. [GOC:mah] |
Involved In
This protein is involved in 25 target(s):
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
response to yeast | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species. [PMID:14707091] |
leukocyte migration involved in inflammatory response | biological process | The movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response. [GOC:add, ISBN:0781735149, PMID:14680625, PMID:14708592, PMID:7507411, PMID:8600538] |
biosynthetic process of antibacterial peptides active against Gram-negative bacteria | biological process | The chemical reactions and pathways resulting in the formation of an antibacterial peptide with activity against Gram-negative bacteria. [GOC:add, PMID:11807545] |
proteolysis | biological process | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. [GOC:bf, GOC:mah] |
intracellular calcium ion homeostasis | biological process | A homeostatic process involved in the maintenance of a steady state level of calcium ions within a cell. [GOC:ceb, GOC:mah] |
response to UV | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. [GOC:hb] |
extracellular matrix disassembly | biological process | A process that results in the breakdown of the extracellular matrix. [GOC:jid] |
protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. [GOC:mah] |
response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:add, ISBN:0721601464] |
negative regulation of chemokine production | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine production. [GOC:mah] |
negative regulation of interleukin-8 production | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production. [GOC:mah] |
positive regulation of interleukin-8 production | biological process | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. [GOC:mah] |
defense response to bacterium | biological process | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. [GOC:jl] |
positive regulation of MAP kinase activity | biological process | Any process that activates or increases the frequency, rate or extent of MAP kinase activity. [GOC:dph, GOC:go_curators] |
positive regulation of smooth muscle cell proliferation | biological process | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. [CL:0000192, GOC:ebc] |
negative regulation of inflammatory response | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. [GOC:ai] |
positive regulation of immune response | biological process | Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. [GOC:ai] |
negative regulation of chemotaxis | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. [GOC:ai] |
pyroptosis | biological process | A caspase-1-dependent cell death subroutine that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. [GOC:mtg_apoptosis, PMID:18846107, PMID:21760595] |
neutrophil-mediated killing of gram-negative bacterium | biological process | The directed killing of a gram-negative bacterium by a neutrophil. [GOC:add, ISBN:0781765196] |
neutrophil-mediated killing of fungus | biological process | The directed killing of a fungal cell by a neutrophil. [GOC:add, ISBN:0781765196] |
positive regulation of leukocyte tethering or rolling | biological process | Any process that activates or increases the frequency, rate or extent of leukocyte tethering or rolling. [GO_REF:0000058, GOC:als, GOC:TermGenie, PMID:18308860] |
phagocytosis | biological process | A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. [ISBN:0198506732] |
acute inflammatory response to antigenic stimulus | biological process | An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response. [GO_REF:0000022, GOC:add, ISBN:0781735149] |